ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Nov 22, 2024
Dividend Increases/Decreases for the Week of November 22
Let's take a look at firms raising/lowering their dividends this week.
Nov 15, 2024
Cisco Raises Fiscal 2025 Guidance
Image: Cisco’s shares have been choppy the past couple years. Looking to fiscal 2025, Cisco Systems expects revenue in the range of $55.3-$56.3 billion, up from a prior view of $55-$56.2 billion, and non-GAAP earnings per share in the range of $3.60-$3.66, up from $3.52-$3.58 previously. We like Cisco’s progression to a subscription base business model, its opportunities in artificial intelligence, while its forward price-to-earnings ratio remains attractive at roughly 16x current fiscal year earnings. The high end of our fair value estimate range is $67 per share.
Nov 15, 2024
Dividend Increases/Decreases for the Week of November 15
Let's take a look at firms raising/lowering their dividends this week.
Nov 8, 2024
Dividend Increases/Decreases for the Week of November 8
Let's take a look at firms raising/lowering their dividends this week.
Nov 7, 2024
Albemarle Pursues Efficiency in the Wake of Lower Lithium Prices
Image Source: Albemarle. Albemarle is working hard in the face of weak lithium pricing, and the firm is driving cost and productivity improvements across its business. The firm noted that it is reducing its workforce by 6%-7%, which will help the company cut costs in the range of $300-$400 million, and it plans to decrease its fiscal 2025 capital spending by roughly half versus fiscal 2024 ($1.7-$1.8 billion), to an expected range of $800-$900 million. Total liquidity was $3.4 billion at the end of the quarter, including $1.7 billion in cash equivalents, while total debt was $3.6 billion. We continue to include Albemarle in the ESG Newsletter portfolio.
Nov 6, 2024
Cash-Rich Vertex Pharma Raises 2024 Product Revenue Guidance
Image: Vertex Pharma’s shares have done quite well the past couple years. We continue to like Vertex’s established position in cystic fibrosis and its opportunity in gene-editing therapies as well as a new class of medicine for acute pain (VX-548) that’s without the limitations of opioids. The company’s pipeline is also progressing nicely with three additional programs advancing to Phase 3 – suzetrigine in painful diabetic peripheral neuropathy (DPN), povetacicept in immunoglobulin A nephropathy (IgAN), and VX-880 in Type 1 diabetes (T1D). The high end of our fair value estimate range for Vertex stands at $640 per share.
Nov 4, 2024
Berkshire Hathaway’s Operating Earnings, Free Cash Flow Fall in Third Quarter
Image: Berkshire Hathaway has reduced its stake in Apple and Bank of America. Berkshire’s third quarter operating results weren’t great, and the firm noted that it expects pre-tax incurred losses from Hurricane Milton to be between $1.3-$1.5 billion and be reflected in its fourth quarter earnings. Free cash flow has faced some pressure during the first nine months of the year, and Buffett continues to cash out of Apple and Bank of America. Berkshire’s cash balance continues to swell, perhaps indicating that Buffett views the market as overheated at the moment. Total shareholders’ equity was $631.8 billion at the end of September, translating into a price-to-book ratio of 1.54. Shares of Berkshire are not cheap, in our view, but the company remains a key holding in the Best Ideas Newsletter portfolio.
Nov 4, 2024
Amazon’s Operating Profit Surprises to the Upside
Image: Amazon’s shares have done quite well since the beginning of 2023. Looking to the fourth quarter of 2024, Amazon's net sales are expected to be between $181.5 billion and $188.5 billion, growing 7%-11% compared with the fourth quarter of 2023 and the midpoint slightly below consensus of $186.4 billion. The top line guidance assumes an unfavorable impact of roughly 10 basis points from currency fluctuations. Operating income in the quarter is targeted in the range of $16-$20 billion, compared with $13.2 billion in the fourth quarter of 2023 and the midpoint above consensus of $17.5 billion. Amazon ended the quarter with $88 billion in cash and marketable securities and $54.9 billion in long-term debt.
Nov 1, 2024
Dividend Increases/Decreases for the Week of November 1
Let's take a look at firms raising/lowering their dividends this week.
Oct 31, 2024
Altria Reaffirms 2024 Full Year Guidance
Image: Altria’s shares have recovered nicely during 2024. Altria paid dividends of $1.7 billion and $5.1 billion during the third quarter and the first nine months, respectively. The 4.1% increase in its dividend in August marked the 59th increase during the past 55 years. Management’s guidance calls for a mid-single-digits annual increase in its per-share payout through 2028. We liked Altria’s operating income growth in its Smokeable Products segment in the quarter, and we’re fans of its plans for the dividend the next few years. Altria remains a key idea in the High Yield Dividend Newsletter portfolio.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.